publication date: Aug 5, 2011
|
author/source: The Scott Partnership
Exco InTouch, the leading provider of patient communication
solutions for the pharmaceutical and healthcare sectors, has announced that its
novel eDiary technologies have been selected by Pfizer, the world's leading
pharmaceutical company, as part of the first ever Participatory
Patient-Centered (PPC) clinical trial. The pilot study will utilize Exco
InTouch's leading eDiary technologies to enable patients to participate
regardless of location, age or proximity to site. Focusing on new Research on Electronic
Monitoring of OAB Treatment Experience (REMOTE) Phase 4 for the treatment of
overactive bladder, the study will mimic a previously completed trial in order
to replicate the results and validate this novel approach.
In order to support the success of this patient-centered,
field-based clinical research, Pfizer required a mobile technology platform
offering an ease-of-use interface that provided accessibility particularly for
older patients. With an estimated five
billion cellphone users worldwide, cell phones make an ideal and accessible
platform for patient engagement in clinical trials. As part of the
revolutionary new approach piloted by the REMOTE study, patients will be
empowered to participate remotely in the screening process through trials via
the internet, participate in trials that due to location may not have
previously been possible, actively manage their own trial and report results
directly to a trial. As a result, researchers expect to save time and obtain
more reliable, higher quality data through increased patient compliance and
engagement, lower withdrawal rates and real-time data collection. The new
approach will also eliminate the significant costs associated with the
management and co-ordination of running multiple clinical sites.
Exco InTouch offers three validated ePRO solutions, spanning
simple diaries to the most complex clinical assessments, all of which can be
customized to meet the requirements of individual trials. These technologies
have been developed with an intuitive design to provide easy navigation that
enhances the user experience, while positively impacting on-going compliance
from patients, regardless of their age and logistics. Where specific and
targeted data collection is required, patients can complete diary
questionnaires via a series of text messages sent to their own cellphone. If a
response is not received by the patient within a certain timeframe, a text
message reminder can be automatically sent in order to prompt a response. The
ability to capture patient data in "real-time" means that investigator site staff
can be alerted to abnormal patient data and react to ensure patient safety.
"The REMOTE virtual trial pilot brings great potential to
transform how patients access and participate in clinical trials," said Miguel
Orri MD,
Senior Director and Clinical Lead, Pfizer. "The project brings the potential to accelerate clinical research while improving
quality, measures vital to the future of drug development."
Tim Davis, CEO of Exco InTouch, comments: "Exco InTouch
is delighted that its leading ePRO technology has been selected to support such
a revolutionary new study. The intuitive, light-weight and accessible nature of
the Exco InTouch eDiary technology meant it was the natural choice for Pfizer
in its efforts to increase access to clinical trials for the broadest patient
population."
For further information on the Exco InTouch range of
solutions, please call +44 1279 709 040 or +1 877 327 5777 or visit
www.excointouch.com.
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.